On The Line: Is Canada finally moving on from the pipeline wars?
About this episode
The episode discusses Canadian energy policy and the challenges of accessing cancer treatments through clinical trials.
In this episode of On The Line , host Jen Gerson is joined by Andrew Leach, noted energy and environmental economist and professor of economics and law at the University of Alberta, for a conversation about Canadian energy policy at a pivotal moment. This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network bringing cutting edge cancer immunotherapy research from Canadian labs to patients in clinical trials –– all in Canada. A drug that can treat your cancer is being tested in a Canadian clinical trial, but can you access it? Depends — where do you live? Clinical trials taking place in Canada usually open sites in major centers with research hospitals. Smaller hospitals face many challenges including having enough know-how to deliver experimental therapies, and administrative, legal, and regulatory responsibilities that come with a trial. There are also data and interoperability issues at hospitals that don’t routinely participate in research. So if you don’t live in a major centre, participating in the trial requires you to relocate there for the duration of treatment –– the cost of the treatment is covered, but the cost of being in…
Sponsors
BioCanRx
More episodes of The Line Podcast
- The Line Podcast: Our smoke attack on America has achieved total success
- On The Line: Canada can build transportation gooder (and sometimes, we did build good)
- The Line Podcast: Carney is building a new post-America world
- The Line Podcast: Carney gets a pipeline deal. Now let's build the damn thing
- On The Line: On the frontlines of emergency health care in Canada
- The Line Podcast: Carney makes the easy call to fix our most symbolic national disgrace
Explore listener stats, chart rankings, contacts and more on the The Line Podcast podcast page.